Home :: Health :: Atherosclerosis

Latest Atherosclerosis News

Organon and Shanghai Genomics to Collaborate on New Research ... - PR Web (press release)

Oss, The Netherlands (PRWEB) January 24, 2006 -- Organon, the human healthcare business of Akzo Nobel, and Shanghai Genomics Inc, the China-based affiliate of GNI and one of China’s leading biotech companies, today announced an agreement to collaborate on a new research project. The collaboration, which will involve biological development work aimed at progressing Organon’s program for the identification of More selective steroid hormone receptor modulators, will initially last for a period of two years. Shanghai Genomics, which in 2005 merged with GNI Ltd., the Asia-based global pharmaceutical company, will use its expertise in protein purification and cell-based interaction assays to clarify the clinical relevance of a number of receptor interacting proteins and their use in drug discovery. In particular, the research will focus upon the areas of Rheumatoid Arthritis, atherosclerosis and oncology. “We are delighted to have successfully finalized this new research partnership with Shanghai Genomics as part of our research strategy to forge closer links with China’s highly skilled and motivated scientists. This is now the second major research collaboration deal that Organon has recently finalized in China,” said Dr David Nicholson, Executive Vice President Global Research, Organon International Inc. ”We are confident that Shanghai Genomics’ integrated drug - More available

Atherosclerosis

No Ebay Marketplace Listings Found